作者: Philipp Y. Maximov , Russell E. McDaniel , V. Craig Jordan
DOI: 10.1007/978-3-0348-0664-0_3
关键词:
摘要: By the early 1970s, a number of metabolites tamoxifen had been identified in animals and following administration to few patients. The hydroxylated metabolite tamoxifen, 4-hydroxytamoxifen, proved be most interesting. discovery its high binding affinity for estrogen receptor made it new laboratory tool all future vitro studies antiestrogen action also provided clue structure-function relationships antiestrogens. These compounds would subsequently developed as selective modulators (SERMs). Tamoxifen is prodrug but 4-hydroxy-N-desmethyltamoxifen or endoxifen that has attracted pharmacogenetic interest. Mutations CYP2D6 gene control production have associated with drug efficacy some clinical trials.